Within the 140 trading days in the period, the benchmark Shanghai Composite Index had not closed up ... reduced price swings in arguably the world’s most volatile emerging stock market, it has also come at a cost of waning trading activities among ... ( read original story ...)
China Ends Curbs on Derivatives as Stock Market Stabilizes
“Recent operational data also suggest that the stock market is improving on a steady foundation.” The regulator added that during the first seven months of this year, the Shanghai Stock Exchange Composite Index largely hovered between 3,000 and 3,300 ... ( read original story ...)
Shanghai RAAS Blood Products Co Ltd 002252 Financial and Strategic SWOT Analysis Review [Report Updated: 18072017] Prices from USD $125
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform... Blood is a specialized bodily fluid that delivers necessary ... ( read original story ...)
China fines Citibank, four others for breaching mortgage and credit card rules
US banking giant Citigroup has been fined 10 million yuan (US$1.6 million) by China’s financial watchdog in Shanghai, accused of violating mortgage lending rules and for showing insufficient care when issuing credit cards. According to the China Banking ... ( read original story ...)
BRIEF-Joinn Laboratories China to raise up to 256.5 mln yuan for Shanghai IPO
* Joinn laboratories china says it plans to raise up to 256.5 million yuan ($38.51 million) at 12.51 yuan per share for its shanghai ipo ( read original story ...)
China approves 8 IPO applications
Four of them will be listed on the Shanghai stock exchange, one on the Shenzhen small and medium enterprise board, and three on the ChiNext, China's NASDAQ-style board. The firms and their underwriters will confirm IPO dates and publish prospectuses ... ( read original story ...)
Pfizer Alum’s China Startup Is Said to Select Banks for IPO
The Shanghai-based biopharmaceutical company ... Wuxi Biologics Cayman Inc. has risen 53 percent from the offer price in its June IPO, making it the best performer this year among Hong Kong new listings that raised more than $500 million, according ... ( read original story ...)